Apogee Therapeutics, Inc. Operating Lease Liability
Apogee Therapeutics, Inc. (APGE) had Operating Lease Liability of $8.85 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-02
- 2025-12-31: Operating Lease, Liability $8.85M.
- 2024-12-31: Operating Lease, Liability $11.83M.
- 2024-06-30: Operating Lease, Liability $4.10M.
- 2023-12-31: Operating Lease, Liability $2.00M; Operating Lease, Liability as first filed $2.03M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $8.85M 10-K · filed 2026-03-02 | |
| 2024-12-31 | $11.83M 10-K · filed 2025-03-03 | |
| 2024-06-30 | $4.10M 10-Q · filed 2024-08-12 | |
| 2023-12-31 | $2.00M 10-Q · filed 2024-08-12 | $2.03M 10-K · filed 2024-03-05 |